News sentiment for the state-run mineral producer NMDC soared to the highest level in the past 12-months as the positive media coverage gained momentum during December 2017. At 51, Heckyl sentiment score 50-day moving average (DMA) was at the highest in the past 1-year on Jan. 2, 2018.
At the same time, positive press coverage was also reflected in the share price (Image 1). Since November 30, NMDC has appreciated nearly 17% as buoyant news sentiment fueled optimism about the future prospects.
Production, ratings, contracts, product pricing, and expansion related news items dominated NMDC’s media coverage in the past 1-month (Image 2). Moreover, news coverage under these categories was extremely positive during this period.
Cadila Healthcare secured the highest number of ANDA (abbreviated new drug application) approvals among Indian pharmaceutical companies during the past nine month period.
The country’s fourth-largest drugmaker by market cap has received 70 ANDA approvals in the current financial year (Image 1). Out the total, 21 ANDA approvals were received by the company during the previous quarter.
The drug makers are required to obtain ANDA approval from the FDA to manufacture and market the low-cost generic alternative to the brand-name drug in the US market.
Product launch, alternative energy top news topics for global automakers
Surge in news volume highlighting alternative energy signals the automotive industry is moving towards electric vehicles at top speed
Tesla Inc. topped the media coverage among 20 major global automakers in 2017 followed by Volkswagen, Ford Motor, and Toyota (Image 1). Tesla generated a lot of media frenzy around its market launch of Model 3 and unveiling of Roadster and Tesla Semi during this year.
FiND, an alternative data platform showed a surge in news flow highlighting alternative energy for all major automakers globally (Image 2). Automotive product launches generate lots of media coverage and thus it topping the list is understandable.
Read the rest of this entry »
French drug-maker Sanofi faces risk to its 16% of revenues after its top-selling drug Lantus came under threat from the generic manufacturers. The fear of losing revenue from Lantus has forced Sanofi to defend its intellectual property rights. Recent news flow showed that the maker of Lantus drug filed several patent infringement suits against the generic manufacturers.
Lantus, an “Insulin glargine” (a long-acting basal insulin analogue), accounted for 16.4% of Sanofi’s net sales in 2016. Lantus consists of microcrystals, which slowly releases insulin over a period of 24 hours with a peak-less profile. This drug helps in controlling the blood sugar of diabetic people.
Lantus is one of the major drugs in the anti-diabetic segment. In 2015, Lantus accounted for ~17% of the global sales for anti-diabetic products.
Delta Air Lines rallied on Tuesday after the company issued better-than-expected guidance for the third quarter passenger unit revenue. Despite fall in passenger traffic in September 2017, Delta management expects passenger unit revenue to increase by 2% for the quarter ended September 2017.
In September, operations of few US-based airlines including Delta were affected by the Hurricane Irma. Bad weather conditions forced Delta to cancel 22,000 flights in the last month. As a result, the carrier reported a drop of 2.3% (on a year-on-year basis) in the number of passengers carried during September.
Heckyl’s alternative data platform FiND did not show any major impact of Hurricane Irma on Delta’s operational performance for the quarter ended September 2017. Our analysis showed a growth of 3% (on a y-o-y basis) in the number of passengers carried by Delta during the quarter ended September 2017.
The 7.1 magnitude earthquake that hit Mexico on September 19 has left auto OEMs, suppliers and dealers worried on possible production and sales losses, if any. Fortunately, Central Mexico, the worst affected area, has fewer manufacturing plants compared to other parts of the country.
But as a participant in the auto supply chain, are you well prepared to hedge or possibly gain out of the situations like these?
FiND, a brand new Alternative Data platform, can not only alert you about the OEMs and plants which are worse impacted by the supply disruptions but also can provide information about the models and parts produced in these plants.